Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2007

01-02-2007 | Letter

Carbon dioxide removal device: how long is long enough?

Authors: Manuel E Cevallos, Joseph B Zwischenberger

Published in: Critical Care | Issue 1/2007

Login to get access

Excerpt

Livigni and coworkers [1] reported on the safety and efficacy of a venovenous carbon dioxide removal (VVCO2R) circuit in a short-term study (to 12 hours) conducted in healthy sheep. During extracorporeal carbon dioxide removal, carbon dioxide is transferred across a gas exchanger whereas oxygen diffuses across the native lungs. …
Literature
1.
Livigni S, Maio M, Ferretti E, Longobardo A, Potenza R, Rivalta L, Selvaggi P, Vergano M, Bertolini G: Efficacy and safety of a low flow veno-venous carbon dioxide removal device: results of an experimental study in adult sheep. Crit Care 2006, 10: R151. 10.1186/cc5082PubMedCentralCrossRefPubMed
2.
Kolobow T, Zapol W, Pierce J: High survival and minimal blood damage in lambs exposed to long term (1 week) veno-venous pumping with a polyurethane chamber roller pump with and without a membrane blood oxygenator. Trans Am Soc Artif Intern Organs 1969, 15: 172-177.PubMed
3.
Kolobow T, Borelli M, Spatola R, Tsuno K, Prato P: Single catheter veno-venous membrane lung bypass in the treatment of experimental ARDS. ASAIO Trans 1988, 34: 35-38.PubMed
4.
Morris AH, Wallace CJ, Menlove RL, Clemmer TP, Orme JF Jr, Weaver LK, Dean NC, Thomas F, East TD, Pace NL, et al.: Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994, 149: 295-305.CrossRefPubMed
5.
Alpard SK, Zwischenberger JB, Tao W, Deyo DJ, Traber DL, Bidani A: New clinically relevant sheep model of severe respiratory failure secondary to combined smoke inhalation/cutaneous flame burn injury. Crit Care Med 2000, 28: 1469-1476. 10.1097/00003246-200005000-00036CrossRefPubMed
6.
Cevallos M, Schmalstieg F, Wang D, Campbell K, Zwischenberger J: Mortality benefit in LD 100 Smoke/Burn Induced ARDS by AVCO 2 R in Sheep [abstract]. ASAIO J 2006, 52: 68A. 10.1097/00002480-200603000-00288CrossRef
7.
Kolobow T: The (ir)relevance of short term studies. Int J Artif Organs 1990, 13: 1-2.PubMed
Metadata
Title
Carbon dioxide removal device: how long is long enough?
Authors
Manuel E Cevallos
Joseph B Zwischenberger
Publication date
01-02-2007
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2007
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc5130

Other articles of this Issue 1/2007

Critical Care 1/2007 Go to the issue

Research

Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial

Commentary

Doing research on the ethics of doing research

Research

Managing an effective treatment for neuroleptic malignant syndrome

Research

The impact of admission diagnosis on gastric emptying in critically ill patients

Letter

Acute renal failure in critically ill HIV-infected patients

Commentary

Research in critically ill patients: standards of informed consent